                         SEQUENCE LISTING

<110>  ITH Immune Therapy Holdings AB
 
<120>  TREATING CONDITIONS ASSOCIATED WITH ALLERGY

<130>  P117757WO00

<160>  20    

<170>  PatentIn version 3.5

<210>  1
<211>  97
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide

<400>  1

Met Lys Val Ser Ala Ala Leu Leu Trp Leu Leu Leu Ile Ala Ala Ala 
1               5                   10                  15      


Phe Ser Pro Gln Gly Leu Ala Gly Pro Ala Ser Val Pro Thr Thr Cys 
            20                  25                  30          


Cys Phe Asn Leu Ala Asn Arg Lys Ile Pro Leu Gln Arg Leu Glu Ser 
        35                  40                  45              


Tyr Arg Arg Ile Thr Ser Gly Lys Cys Pro Gln Lys Ala Val Ile Phe 
    50                  55                  60                  


Lys Thr Lys Leu Ala Lys Asp Ile Cys Ala Asp Pro Lys Lys Lys Trp 
65                  70                  75                  80  


Val Gln Asp Ser Met Lys Tyr Leu Asp Gln Lys Ser Pro Thr Pro Lys 
                85                  90                  95      


Pro 
    


<210>  2
<211>  74
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide

<400>  2

Gly Pro Ala Ser Val Pro Thr Thr Cys Cys Phe Asn Leu Ala Asn Arg 
1               5                   10                  15      


Lys Ile Pro Leu Gln Arg Leu Glu Ser Tyr Arg Arg Ile Thr Ser Gly 
            20                  25                  30          


Lys Cys Pro Gln Lys Ala Val Ile Phe Lys Thr Lys Leu Ala Lys Asp 
        35                  40                  45              


Ile Cys Ala Asp Pro Lys Lys Lys Trp Val Gln Asp Ser Met Lys Tyr 
    50                  55                  60                  


Leu Asp Gln Lys Ser Pro Thr Pro Lys Pro 
65                  70                  


<210>  3
<211>  76
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (1)..(1)
<223>  X = pyroGlu or Gln

<400>  3

Xaa Pro Asp Ser Val Ser Ile Pro Ile Thr Cys Cys Phe Asn Val Ile 
1               5                   10                  15      


Asn Arg Lys Ile Pro Ile Gln Arg Leu Glu Ser Tyr Thr Arg Ile Thr 
            20                  25                  30          


Asn Ile Gln Cys Pro Lys Glu Ala Val Ile Phe Lys Thr Lys Arg Gly 
        35                  40                  45              


Lys Glu Val Cys Ala Asp Pro Lys Glu Arg Trp Val Arg Asp Ser Met 
    50                  55                  60                  


Lys His Leu Asp Gln Ile Phe Gln Asn Leu Lys Pro 
65                  70                  75      


<210>  4
<211>  76
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (1)..(1)
<223>  X = pyroGlu or Gln

<220>
<221>  X
<222>  (75)..(75)
<223>  X is K(ivDde)

<400>  4

Xaa Pro Asp Ser Val Ser Ile Pro Ile Thr Cys Cys Phe Asn Val Ile 
1               5                   10                  15      


Asn Arg Lys Ile Pro Ile Gln Arg Leu Glu Ser Tyr Thr Arg Ile Thr 
            20                  25                  30          


Asn Ile Gln Cys Pro Lys Glu Ala Val Ile Phe Lys Thr Lys Arg Gly 
        35                  40                  45              


Lys Glu Val Cys Ala Asp Pro Lys Glu Arg Trp Val Arg Asp Ser Met 
    50                  55                  60                  


Lys His Leu Asp Gln Ile Phe Gln Asn Leu Xaa Pro 
65                  70                  75      


<210>  5
<211>  76
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (1)..(1)
<223>  X = pyroGlu or Gln

<220>
<221>  X
<222>  (75)..(75)
<223>  X is an amino acid residue that can be biotinylated, such as 
       lysine, ornithine or diaminopropionic acid and optionally is 
       biotinylated, optionally via a spacer molecule such as PEG, e.g. 
       K(PEG-Biotin)

<400>  5

Xaa Pro Asp Ser Val Ser Ile Pro Ile Thr Cys Cys Phe Asn Val Ile 
1               5                   10                  15      


Asn Arg Lys Ile Pro Ile Gln Arg Leu Glu Ser Tyr Thr Arg Ile Thr 
            20                  25                  30          


Asn Ile Gln Cys Pro Lys Glu Ala Val Ile Phe Lys Thr Lys Arg Gly 
        35                  40                  45              


Lys Glu Val Cys Ala Asp Pro Lys Glu Arg Trp Val Arg Asp Ser Met 
    50                  55                  60                  


Lys His Leu Asp Gln Ile Phe Gln Asn Leu Xaa Pro 
65                  70                  75      


<210>  6
<211>  68
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide

<400>  6

Ser Pro Tyr Ser Ser Asp Thr Thr Pro Cys Cys Phe Ala Tyr Ile Ala 
1               5                   10                  15      


Arg Pro Leu Pro Arg Ala His Ile Lys Glu Tyr Phe Tyr Thr Ser Gly 
            20                  25                  30          


Lys Cys Ser Asn Pro Ala Val Val Phe Val Thr Arg Lys Asn Arg Gln 
        35                  40                  45              


Val Cys Ala Asn Pro Glu Lys Lys Trp Val Arg Glu Tyr Ile Asn Ser 
    50                  55                  60                  


Leu Glu Lys Ser 
65              


<210>  7
<211>  68
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (67)..(67)
<223>  X is K(ivDde)

<400>  7

Ser Pro Tyr Ser Ser Asp Thr Thr Pro Cys Cys Phe Ala Tyr Ile Ala 
1               5                   10                  15      


Arg Pro Leu Pro Arg Ala His Ile Lys Glu Tyr Phe Tyr Thr Ser Gly 
            20                  25                  30          


Lys Cys Ser Asn Pro Ala Val Val Phe Val Thr Arg Lys Asn Arg Gln 
        35                  40                  45              


Val Cys Ala Asn Pro Glu Lys Lys Trp Val Arg Glu Tyr Ile Asn Ser 
    50                  55                  60                  


Leu Glu Xaa Ser 
65              


<210>  8
<211>  68
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (67)..(67)
<223>  X is an amino acid residue that can be biotinylated, such as 
       lysine, ornithine or diaminopropionic acid and optionally is 
       biotinylated, optionally via a spacer molecule such as PEG, e.g. 
       K(PEG-Biotin)

<400>  8

Ser Pro Tyr Ser Ser Asp Thr Thr Pro Cys Cys Phe Ala Tyr Ile Ala 
1               5                   10                  15      


Arg Pro Leu Pro Arg Ala His Ile Lys Glu Tyr Phe Tyr Thr Ser Gly 
            20                  25                  30          


Lys Cys Ser Asn Pro Ala Val Val Phe Val Thr Arg Lys Asn Arg Gln 
        35                  40                  45              


Val Cys Ala Asn Pro Glu Lys Lys Trp Val Arg Glu Tyr Ile Asn Ser 
    50                  55                  60                  


Leu Glu Xaa Ser 
65              


<210>  9
<211>  76
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (1)..(1)
<223>  X = pyroGlu or Gln

<400>  9

Xaa Pro Asp Ala Ile Asn Ala Pro Val Thr Cys Cys Tyr Asn Phe Thr 
1               5                   10                  15      


Asn Arg Lys Ile Ser Val Gln Arg Leu Ala Ser Tyr Arg Arg Ile Thr 
            20                  25                  30          


Ser Ser Lys Cys Pro Lys Glu Ala Val Ile Phe Lys Thr Ile Val Ala 
        35                  40                  45              


Lys Glu Ile Cys Ala Asp Pro Lys Gln Lys Trp Val Gln Asp Ser Met 
    50                  55                  60                  


Asp His Leu Asp Lys Gln Thr Gln Thr Pro Lys Thr 
65                  70                  75      


<210>  10
<211>  76
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (1)..(1)
<223>  X = pyroGlu or Gln

<220>
<221>  X
<222>  (75)..(75)
<223>  X is K(ivDde)

<400>  10

Xaa Pro Asp Ala Ile Asn Ala Pro Val Thr Cys Cys Tyr Asn Phe Thr 
1               5                   10                  15      


Asn Arg Lys Ile Ser Val Gln Arg Leu Ala Ser Tyr Arg Arg Ile Thr 
            20                  25                  30          


Ser Ser Lys Cys Pro Lys Glu Ala Val Ile Phe Lys Thr Ile Val Ala 
        35                  40                  45              


Lys Glu Ile Cys Ala Asp Pro Lys Gln Lys Trp Val Gln Asp Ser Met 
    50                  55                  60                  


Asp His Leu Asp Lys Gln Thr Gln Thr Pro Xaa Thr 
65                  70                  75      


<210>  11
<211>  76
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (1)..(1)
<223>  X = pyroGlu or Gln

<220>
<221>  X
<222>  (75)..(75)
<223>  X is an amino acid residue that can be biotinylated, such as 
       lysine, ornithine or diaminopropionic acid and optionally is 
       biotinylated, optionally via a spacer molecule such as PEG, e.g. 
       K(PEG-Biotin)

<400>  11

Xaa Pro Asp Ala Ile Asn Ala Pro Val Thr Cys Cys Tyr Asn Phe Thr 
1               5                   10                  15      


Asn Arg Lys Ile Ser Val Gln Arg Leu Ala Ser Tyr Arg Arg Ile Thr 
            20                  25                  30          


Ser Ser Lys Cys Pro Lys Glu Ala Val Ile Phe Lys Thr Ile Val Ala 
        35                  40                  45              


Lys Glu Ile Cys Ala Asp Pro Lys Gln Lys Trp Val Gln Asp Ser Met 
    50                  55                  60                  


Asp His Leu Asp Lys Gln Thr Gln Thr Pro Xaa Thr 
65                  70                  75      


<210>  12
<211>  78
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (78)..(78)
<223>  X is an amino acid residue that can be biotinylated, such as 
       lysine, ornithine or diaminopropionic acid and optionally is 
       biotinylated, optionally via a spacer molecule such as PEG, e.g. 
       K(PEG-Biotin)

<400>  12

Ala Val Leu Pro Arg Ser Ala Lys Glu Leu Arg Cys Gln Cys Ile Lys 
1               5                   10                  15      


Thr Tyr Ser Lys Pro Phe His Pro Lys Phe Ile Lys Glu Leu Arg Val 
            20                  25                  30          


Ile Glu Ser Gly Pro His Cys Ala Asn Thr Glu Ile Ile Val Lys Leu 
        35                  40                  45              


Ser Asp Gly Arg Glu Leu Cys Leu Asp Pro Lys Glu Asn Trp Val Gln 
    50                  55                  60                  


Arg Val Val Glu Lys Phe Leu Lys Arg Ala Glu Asn Ser Xaa 
65                  70                  75              


<210>  13
<211>  78
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (78)..(78)
<223>  X is K(ivDde)

<400>  13

Ala Val Leu Pro Arg Ser Ala Lys Glu Leu Arg Cys Gln Cys Ile Lys 
1               5                   10                  15      


Thr Tyr Ser Lys Pro Phe His Pro Lys Phe Ile Lys Glu Leu Arg Val 
            20                  25                  30          


Ile Glu Ser Gly Pro His Cys Ala Asn Thr Glu Ile Ile Val Lys Leu 
        35                  40                  45              


Ser Asp Gly Arg Glu Leu Cys Leu Asp Pro Lys Glu Asn Trp Val Gln 
    50                  55                  60                  


Arg Val Val Glu Lys Phe Leu Lys Arg Ala Glu Asn Ser Xaa 
65                  70                  75              


<210>  14
<211>  78
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (78)..(78)
<223>  X is K(PEG-Biotin)

<400>  14

Ala Val Leu Pro Arg Ser Ala Lys Glu Leu Arg Cys Gln Cys Ile Lys 
1               5                   10                  15      


Thr Tyr Ser Lys Pro Phe His Pro Lys Phe Ile Lys Glu Leu Arg Val 
            20                  25                  30          


Ile Glu Ser Gly Pro His Cys Ala Asn Thr Glu Ile Ile Val Lys Leu 
        35                  40                  45              


Ser Asp Gly Arg Glu Leu Cys Leu Asp Pro Lys Glu Asn Trp Val Gln 
    50                  55                  60                  


Arg Val Val Glu Lys Phe Leu Lys Arg Ala Glu Asn Ser Xaa 
65                  70                  75              


<210>  15
<211>  73
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (73)..(73)
<223>  X is an amino acid residue that can be biotinylated, such as 
       lysine, ornithine or diaminopropionic acid and optionally is 
       biotinylated, optionally via a spacer molecule such as PEG, e.g. 
       K(PEG-Biotin)

<400>  15

Ser Ala Lys Glu Leu Arg Cys Gln Cys Ile Lys Thr Tyr Ser Lys Pro 
1               5                   10                  15      


Phe His Pro Lys Phe Ile Lys Glu Leu Arg Val Ile Glu Ser Gly Pro 
            20                  25                  30          


His Cys Ala Asn Thr Glu Ile Ile Val Lys Leu Ser Asp Gly Arg Glu 
        35                  40                  45              


Leu Cys Leu Asp Pro Lys Glu Asn Trp Val Gln Arg Val Val Glu Lys 
    50                  55                  60                  


Phe Leu Lys Arg Ala Glu Asn Ser Xaa 
65                  70              


<210>  16
<211>  73
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (73)..(73)
<223>  X is K(ivDde)

<400>  16

Ser Ala Lys Glu Leu Arg Cys Gln Cys Ile Lys Thr Tyr Ser Lys Pro 
1               5                   10                  15      


Phe His Pro Lys Phe Ile Lys Glu Leu Arg Val Ile Glu Ser Gly Pro 
            20                  25                  30          


His Cys Ala Asn Thr Glu Ile Ile Val Lys Leu Ser Asp Gly Arg Glu 
        35                  40                  45              


Leu Cys Leu Asp Pro Lys Glu Asn Trp Val Gln Arg Val Val Glu Lys 
    50                  55                  60                  


Phe Leu Lys Arg Ala Glu Asn Ser Xaa 
65                  70              


<210>  17
<211>  73
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (73)..(73)
<223>  X is K(PEG-Biotin)

<400>  17

Ser Ala Lys Glu Leu Arg Cys Gln Cys Ile Lys Thr Tyr Ser Lys Pro 
1               5                   10                  15      


Phe His Pro Lys Phe Ile Lys Glu Leu Arg Val Ile Glu Ser Gly Pro 
            20                  25                  30          


His Cys Ala Asn Thr Glu Ile Ile Val Lys Leu Ser Asp Gly Arg Glu 
        35                  40                  45              


Leu Cys Leu Asp Pro Lys Glu Asn Trp Val Gln Arg Val Val Glu Lys 
    50                  55                  60                  


Phe Leu Lys Arg Ala Glu Asn Ser Xaa 
65                  70              


<210>  18
<211>  74
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (73)..(73)
<223>  X is an amino acid residue that can be biotinylated, such as 
       lysine, ornithine or diaminopropionic acid and optionally is 
       biotinylated, optionally via a spacer molecule such as PEG, e.g. 
       K(PEG-Biotin)

<400>  18

Gly Pro Ala Ser Val Pro Thr Thr Cys Cys Phe Asn Leu Ala Asn Arg 
1               5                   10                  15      


Lys Ile Pro Leu Gln Arg Leu Glu Ser Tyr Arg Arg Ile Thr Ser Gly 
            20                  25                  30          


Lys Cys Pro Gln Lys Ala Val Ile Phe Lys Thr Lys Leu Ala Lys Asp 
        35                  40                  45              


Ile Cys Ala Asp Pro Lys Lys Lys Trp Val Gln Asp Ser Met Lys Tyr 
    50                  55                  60                  


Leu Asp Gln Lys Ser Pro Thr Pro Xaa Pro 
65                  70                  


<210>  19
<211>  74
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (73)..(73)
<223>  X is K(ivDde)

<400>  19

Gly Pro Ala Ser Val Pro Thr Thr Cys Cys Phe Asn Leu Ala Asn Arg 
1               5                   10                  15      


Lys Ile Pro Leu Gln Arg Leu Glu Ser Tyr Arg Arg Ile Thr Ser Gly 
            20                  25                  30          


Lys Cys Pro Gln Lys Ala Val Ile Phe Lys Thr Lys Leu Ala Lys Asp 
        35                  40                  45              


Ile Cys Ala Asp Pro Lys Lys Lys Trp Val Gln Asp Ser Met Lys Tyr 
    50                  55                  60                  


Leu Asp Gln Lys Ser Pro Thr Pro Xaa Pro 
65                  70                  


<210>  20
<211>  74
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (73)..(73)
<223>  X is K(PEG-Biotin)

<400>  20

Gly Pro Ala Ser Val Pro Thr Thr Cys Cys Phe Asn Leu Ala Asn Arg 
1               5                   10                  15      


Lys Ile Pro Leu Gln Arg Leu Glu Ser Tyr Arg Arg Ile Thr Ser Gly 
            20                  25                  30          


Lys Cys Pro Gln Lys Ala Val Ile Phe Lys Thr Lys Leu Ala Lys Asp 
        35                  40                  45              


Ile Cys Ala Asp Pro Lys Lys Lys Trp Val Gln Asp Ser Met Lys Tyr 
    50                  55                  60                  


Leu Asp Gln Lys Ser Pro Thr Pro Xaa Pro 
65                  70                  


